Unveiling Disparities, Fostering Awareness, and Building Inclusive Strategies in Diabetic Macular Edema Care

Joseph M. Coney MD, FACS, discusses health equity considerations for patients with diabetic macular edema and the critical role a timely diagnosis and sufficient health literacy plays in effective therapy.

Joseph M. Coney, MD, FACS, discusses the challenges physicians encounter when treating diabetic macular edema and the impact of the disease on patients’ quality of life.

Joseph M. Coney, MD, FACS, reviews best practices for improving adherence to treatment among patients with diabetic macular edema through comprehensive education on the disease and available therapies.

Joseph M. Coney, MD, FACS, explores strategies to address treatment obstacles among vulnerable patients and examines the effects of step therapy and prior authorization within a complex health care landscape.

Joseph M. Coney, MD, FACS, highlights the significance of physician involvement in advocating for patients’ access to approved medications on various levels, including state, community, and national, while also addressing challenges associated with authorizations.

Joseph M. Coney, MD, FACS, discusses the importance of diverse representation in clinical trials for the ongoing advancement of safe and effective treatments, and underscores the need for cultivating trust within communities.

Joseph M. Coney, MD, FACS, discusses the crucial role of ongoing community support and active engagement in boosting clinical trial recruitment and emphasizes the importance of establishing trust and increasing visibility to enhance patient confidence in the process.

Joseph M. Coney, MD, FACS, emphasizes the vital role of community engagement in tackling difference in social determinants of health among patients with diabetes and highlights the significance of multilevel efforts to enhance community health outcomes.

Joseph M. Coney, MD, FACS, underscores the importance of self-reflection to address implicit bias, avoid microaggressions, and foster open communication as key to reducing disparities in health care.

Amy Nguyen Howell, MD, MBA, highlights health equity issues and racial disparities in the prevalence and treatment of diabetic macular edema and emphasizes the influence of social determinants of health aspects on patient outcomes.

Amy Nguyen Howell, MD, MBA, emphasizes ophthalmologists' crucial role in reducing diabetic macular edema (DME) health disparities.

Amy Nguyen Howell, MD, MBA, highlights the importance of data collection, analysis, and the new ICD-10-CMZ codes in understanding and resolving health disparities in diabetic macular edema patient care.

Amy Nguyen Howell, MD, MBA, outlines vital practices for educating diverse patients on diabetic macular edema and its management while highlighting the need for unconscious bias training and social determinants of health screening.

Amy Nguyen Howell, MD, MBA, delves into strategies for health care systems to ensure equitable access and treatments for marginalized individuals with diabetic macular edema.

Amy Nguyen Howell, MD, MBA, outlines vital initiatives and resources to address health disparities in diabetic macular edema care, emphasizing unconscious bias training, CDC resources, academic courses, and collaborative advocacy efforts for promoting health equity.